Possibilities of treatment of multiple sclerosis exacerbations without corticosteroids: A role of metabolic and antioxidant therapy

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 111, Issue 2, 2011, Pages 44-48

  Bisaga, G N ^a   Odinak, M M ^a   Boiko, A N ^a   Mel'nik, Yu B ^a   Popova, N F ^a  

^a NONE

Author keywords

Antioxidant treatment; Cytoflavin; Exacerbation; Metabolic treatment; Multiple sclerosis

Indexed keywords

ANTIBODY; ANTIOXIDANT; CORTICOSTEROID; CYTOFLAVIN; MYELIN PROTEIN; PENTOXIFYLLINE; UNCLASSIFIED DRUG; VITAMIN B GROUP; AUTOANTIBODY; FLAVINE MONONUCLEOTIDE; INOSINE DIPHOSPHATE; METHYLPREDNISOLONE; NICOTINAMIDE; SUCCINIC ACID DERIVATIVE; VITAMIN B COMPLEX;

ADD ON THERAPY; ARTICLE; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFECT; DRUG PULSE THERAPY; DRUG TOLERABILITY; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; ADOLESCENT; ADULT; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE COURSE; DRUG COMBINATION; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; MYELIN SHEATH; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ANTIOXIDANTS; AUTOANTIBODIES; COGNITION; DISEASE PROGRESSION; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; FLAVIN MONONUCLEOTIDE; HUMANS; INOSINE DIPHOSPHATE; LIPID PEROXIDATION; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MYELIN SHEATH; NIACINAMIDE; PENTOXIFYLLINE; SUCCINATES; VITAMIN B COMPLEX; YOUNG ADULT;

EID: 79955645124     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Russian source.
2. Russian source.
3. Russian source.
4. Russian source.
5. Russian source.
6. Russian source.
7. Kurtzke J.F. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
8. Lyons P.R., Newman P.K., Saunders M. Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects. J Neurol Neurosurg Psychiat1988; 51: 2: 285-287.
9. Myhr K.M., Mellgren S.I. Corticosteroids in the treatment of multiple sclerosis. Acta Neurol Scand Suppl 2009; 189: 73-80.
10. Namaka M., Vandenbosch R., Gill R. et al. Corticosteroids and multiple sclerosis: to treat or not to treat. Can Pharm J 2005; 138: 6: 1-13.
11. Polman C.H., Reingold S.C., Edan G. et al. Diagnostic criteria for multiple sclerosis: 2005 revision to the «McDonald Criteria». Ann Neurol 2005; 58: 840-846.
12. Poser C.M., Paty D.W., Scheinberg L. et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
13. Scalfari A., Neuhaus A., Degenhardt A. et al. The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability. Brain 2010; 133: (Pt 7): 1914-1929.
14. 3 exposed rat lungs. Arch Env Health 1982; 37: 3: 167-176.